Skip to main content
OpenTrials

Clinical trial condition

Genital Diseases

Explore clinical trials studying Genital Diseases. Study availability and eligibility vary by location and protocol.

21,662 public trials 3,209 recruiting studies
Refine in advanced search Browse all conditions

Genital Diseases trial results

Recruiting

Study of Treatment for HPV16+ ASC-US or LSIL

NCT03913117

Conditions
ASC-US, Atypical Squamous Cells of the Cervix, Female Urogenital Diseases, +12 more
Locations
  • UAB | The University of Alabama at Birmingham Birmingham, Alabama, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View Trial Details
Recruiting

A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours

NCT04969835

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +33 more
Locations
  • Memorial Sloan Kettering Cancer Center New York, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Fred Hutchinson Cancer Center Seattle, Washington, United States
  • The Beatson West of Scotland Cancer Centre, NHS Greater Glasgow & Clyde Glasgow, United Kingdom
View Trial Details
Recruiting

Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections

NCT06738407

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Chlamydia, +18 more
Locations
  • UCLA Care Los Angeles, California, United States
  • San Francisco Department of Public Health San Francisco, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • University of Florida Tampa, Florida, United States
View all 13 locations
View Trial Details
Recruiting

Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features

NCT05255653

Conditions
Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations
  • The POLEmut-BLUE trial: Princess Margaret Cancer Centre, University of Toronto Toronto, Canada
  • The POLEmut-BLUE trial: University of British Columbia Vancouver, Canada
  • The p53abn-RED trial: Institute Gustave Roussy Villejuif, France
  • Amsterdam University Medical Center Amsterdam, Netherlands
View all 14 locations
View Trial Details

Related conditions